Cereno Scientific’s work is based on the following strategic principles:

  • Development and testing programs shall be sequenced and carried out primarily through external collaborations.
  • Opportunities to finance further development work shall be improved by noting the company’s share on AktieTorget – with the ambition to attract a large number of shareholders to the company.
  • In parallel with the development work, contacts with potential partners shall be nurtured and expanded for the future commercialization of Cereno Scientific’s drug candidates.


BioStock Life Science Summit 2019-10-23 - 2019-10-24

3rd annual Anti-Fibrotic Drug Development Summit (AFDD) 2019-11-18 - 2019-11-20

Nordic-American Life Sciences Conference 2019-12-04 - 2019-12-05

16th Global Cardiovascular Clinical Trialists Forum 2019-12-05 - 2019-12-07

More about us...

Subscribe for corporate news

Follow us on LinkedIn

Follow us on Twitter

Privacy policy

We are proud supporters of World Thrombosis Day. Read more